"Inactive" Ingredients in Pharmaceutical Products: Update (Subject Review)
Because of an increasing number of reports of adverse reactions associated with pharmaceutical excipients, in 1985 the Committee on Drugs issued a position statement1recommending that the Food and Drug Administration mandate labeling of over-the-counter and prescription formulations to include a qua...
Gespeichert in:
| Veröffentlicht in: | Pediatrics (Evanston) 1997-02, Vol.99 (2), p.268-278 |
|---|---|
| 1. Verfasser: | |
| Format: | Artikel |
| Sprache: | eng |
| Schlagworte: | |
| Online-Zugang: | Volltext |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | 278 |
|---|---|
| container_issue | 2 |
| container_start_page | 268 |
| container_title | Pediatrics (Evanston) |
| container_volume | 99 |
| creator | Committee on Drugs |
| description | Because of an increasing number of reports of adverse reactions associated with pharmaceutical excipients, in 1985 the Committee on Drugs issued a position statement1recommending that the Food and Drug Administration mandate labeling of over-the-counter and prescription formulations to include a qualitative list of inactive ingredients. However, labeling of inactive ingredients remains voluntary. Adverse reactions continue to be reported, although some are no longer considered clinically significant, and other new reactions have emerged. The original statement, therefore, has been updated and its information expanded. |
| doi_str_mv | 10.1542/peds.99.2.268 |
| format | Article |
| fullrecord | <record><control><sourceid>gale_proqu</sourceid><recordid>TN_cdi_proquest_journals_228356349</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><galeid>A19119512</galeid><sourcerecordid>A19119512</sourcerecordid><originalsourceid>FETCH-LOGICAL-c604t-e41e3e83c7cc7bda3b616681a3300e5e32117eaeb42a07ed444055691069462b3</originalsourceid><addsrcrecordid>eNptkc9v0zAUxy0EGmVw5B5VHIa0FP9OzG2qYBRV2gTsbDnOS-oqdTrb2eC_x9WmwaTKh2dZn_d91vsg9J7gBRGcftpDGxdKLeiCyvoFmhGs6pLTSrxEM4wZKTnG4jV6E-MWY8xFRU_QicKUc0lm6Pt85Y1N7g7mxcr3AVoHPsXC-eJ6Y8LOWJiSs2YorsPYTjbFz8XNvjUJirOfU7MFm4ofcOfg_uNb9KozQ4R3j_UU3Xz98mv5rVxfXa6WF-vSSsxTCZwAg5rZytqqaQ1rJJGyJoYxjEEAo4RUYKDh1OAKWs45FkIqgqXikjbsFM0fcvdhvJ0gJr0dp-DzSE1pzYRkXGXo_AHqzQDa-W5MwdgePAQzjB46l58viCJECUIzXh7B82lh5-wx_uwZn5EEv1Nvphh1fbl-hp4fQ-04DNCDzqtZXh37iQ1jjAE6vQ9uZ8IfTbA-CNcH4VopTXUWnvkPj9swMWvqgvHWxacmKursnP-L3bh-c-8CHGKcScHZ-N_1KfYvuQi1nQ</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>228356349</pqid></control><display><type>article</type><title>"Inactive" Ingredients in Pharmaceutical Products: Update (Subject Review)</title><source>EZB-FREE-00999 freely available EZB journals</source><creator>Committee on Drugs</creator><creatorcontrib>Committee on Drugs ; Committee on Drugs</creatorcontrib><description>Because of an increasing number of reports of adverse reactions associated with pharmaceutical excipients, in 1985 the Committee on Drugs issued a position statement1recommending that the Food and Drug Administration mandate labeling of over-the-counter and prescription formulations to include a qualitative list of inactive ingredients. However, labeling of inactive ingredients remains voluntary. Adverse reactions continue to be reported, although some are no longer considered clinically significant, and other new reactions have emerged. The original statement, therefore, has been updated and its information expanded.</description><identifier>ISSN: 0031-4005</identifier><identifier>EISSN: 1098-4275</identifier><identifier>DOI: 10.1542/peds.99.2.268</identifier><identifier>PMID: 9024461</identifier><identifier>CODEN: PEDIAU</identifier><language>eng</language><publisher>Elk Grove Village, IL: Am Acad Pediatrics</publisher><subject>Antiasthmatic agents ; Biological and medical sciences ; Complications and side effects ; Excipients ; Food coloring agents ; Food colorings ; Food colouring agents ; General pharmacology ; Labeling ; Medical sciences ; Miscellaneous ; Nonprescription drugs ; Pediatrics ; Pharmacology. Drug treatments ; Prescription drugs ; Side effects</subject><ispartof>Pediatrics (Evanston), 1997-02, Vol.99 (2), p.268-278</ispartof><rights>1997 INIST-CNRS</rights><rights>COPYRIGHT 1997 American Academy of Pediatrics</rights><rights>Copyright American Academy of Pediatrics Feb 1997</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c604t-e41e3e83c7cc7bda3b616681a3300e5e32117eaeb42a07ed444055691069462b3</citedby><cites>FETCH-LOGICAL-c604t-e41e3e83c7cc7bda3b616681a3300e5e32117eaeb42a07ed444055691069462b3</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,776,780,27901,27902</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&idt=2580454$$DView record in Pascal Francis$$Hfree_for_read</backlink></links><search><creatorcontrib>Committee on Drugs</creatorcontrib><creatorcontrib>Committee on Drugs</creatorcontrib><title>"Inactive" Ingredients in Pharmaceutical Products: Update (Subject Review)</title><title>Pediatrics (Evanston)</title><addtitle>Pediatrics</addtitle><description>Because of an increasing number of reports of adverse reactions associated with pharmaceutical excipients, in 1985 the Committee on Drugs issued a position statement1recommending that the Food and Drug Administration mandate labeling of over-the-counter and prescription formulations to include a qualitative list of inactive ingredients. However, labeling of inactive ingredients remains voluntary. Adverse reactions continue to be reported, although some are no longer considered clinically significant, and other new reactions have emerged. The original statement, therefore, has been updated and its information expanded.</description><subject>Antiasthmatic agents</subject><subject>Biological and medical sciences</subject><subject>Complications and side effects</subject><subject>Excipients</subject><subject>Food coloring agents</subject><subject>Food colorings</subject><subject>Food colouring agents</subject><subject>General pharmacology</subject><subject>Labeling</subject><subject>Medical sciences</subject><subject>Miscellaneous</subject><subject>Nonprescription drugs</subject><subject>Pediatrics</subject><subject>Pharmacology. Drug treatments</subject><subject>Prescription drugs</subject><subject>Side effects</subject><issn>0031-4005</issn><issn>1098-4275</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>1997</creationdate><recordtype>article</recordtype><recordid>eNptkc9v0zAUxy0EGmVw5B5VHIa0FP9OzG2qYBRV2gTsbDnOS-oqdTrb2eC_x9WmwaTKh2dZn_d91vsg9J7gBRGcftpDGxdKLeiCyvoFmhGs6pLTSrxEM4wZKTnG4jV6E-MWY8xFRU_QicKUc0lm6Pt85Y1N7g7mxcr3AVoHPsXC-eJ6Y8LOWJiSs2YorsPYTjbFz8XNvjUJirOfU7MFm4ofcOfg_uNb9KozQ4R3j_UU3Xz98mv5rVxfXa6WF-vSSsxTCZwAg5rZytqqaQ1rJJGyJoYxjEEAo4RUYKDh1OAKWs45FkIqgqXikjbsFM0fcvdhvJ0gJr0dp-DzSE1pzYRkXGXo_AHqzQDa-W5MwdgePAQzjB46l58viCJECUIzXh7B82lh5-wx_uwZn5EEv1Nvphh1fbl-hp4fQ-04DNCDzqtZXh37iQ1jjAE6vQ9uZ8IfTbA-CNcH4VopTXUWnvkPj9swMWvqgvHWxacmKursnP-L3bh-c-8CHGKcScHZ-N_1KfYvuQi1nQ</recordid><startdate>19970201</startdate><enddate>19970201</enddate><creator>Committee on Drugs</creator><general>Am Acad Pediatrics</general><general>American Academy of Pediatrics</general><scope>IQODW</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>8GL</scope><scope>7TS</scope><scope>7U9</scope><scope>H94</scope><scope>K9.</scope><scope>M7N</scope><scope>NAPCQ</scope><scope>U9A</scope></search><sort><creationdate>19970201</creationdate><title>"Inactive" Ingredients in Pharmaceutical Products: Update (Subject Review)</title><author>Committee on Drugs</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c604t-e41e3e83c7cc7bda3b616681a3300e5e32117eaeb42a07ed444055691069462b3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>1997</creationdate><topic>Antiasthmatic agents</topic><topic>Biological and medical sciences</topic><topic>Complications and side effects</topic><topic>Excipients</topic><topic>Food coloring agents</topic><topic>Food colorings</topic><topic>Food colouring agents</topic><topic>General pharmacology</topic><topic>Labeling</topic><topic>Medical sciences</topic><topic>Miscellaneous</topic><topic>Nonprescription drugs</topic><topic>Pediatrics</topic><topic>Pharmacology. Drug treatments</topic><topic>Prescription drugs</topic><topic>Side effects</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Committee on Drugs</creatorcontrib><creatorcontrib>Committee on Drugs</creatorcontrib><collection>Pascal-Francis</collection><collection>CrossRef</collection><collection>Gale In Context: High School</collection><collection>Physical Education Index</collection><collection>Virology and AIDS Abstracts</collection><collection>AIDS and Cancer Research Abstracts</collection><collection>ProQuest Health & Medical Complete (Alumni)</collection><collection>Algology Mycology and Protozoology Abstracts (Microbiology C)</collection><collection>Nursing & Allied Health Premium</collection><jtitle>Pediatrics (Evanston)</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Committee on Drugs</au><aucorp>Committee on Drugs</aucorp><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>"Inactive" Ingredients in Pharmaceutical Products: Update (Subject Review)</atitle><jtitle>Pediatrics (Evanston)</jtitle><addtitle>Pediatrics</addtitle><date>1997-02-01</date><risdate>1997</risdate><volume>99</volume><issue>2</issue><spage>268</spage><epage>278</epage><pages>268-278</pages><issn>0031-4005</issn><eissn>1098-4275</eissn><coden>PEDIAU</coden><abstract>Because of an increasing number of reports of adverse reactions associated with pharmaceutical excipients, in 1985 the Committee on Drugs issued a position statement1recommending that the Food and Drug Administration mandate labeling of over-the-counter and prescription formulations to include a qualitative list of inactive ingredients. However, labeling of inactive ingredients remains voluntary. Adverse reactions continue to be reported, although some are no longer considered clinically significant, and other new reactions have emerged. The original statement, therefore, has been updated and its information expanded.</abstract><cop>Elk Grove Village, IL</cop><pub>Am Acad Pediatrics</pub><pmid>9024461</pmid><doi>10.1542/peds.99.2.268</doi><tpages>11</tpages><oa>free_for_read</oa></addata></record> |
| fulltext | fulltext |
| identifier | ISSN: 0031-4005 |
| ispartof | Pediatrics (Evanston), 1997-02, Vol.99 (2), p.268-278 |
| issn | 0031-4005 1098-4275 |
| language | eng |
| recordid | cdi_proquest_journals_228356349 |
| source | EZB-FREE-00999 freely available EZB journals |
| subjects | Antiasthmatic agents Biological and medical sciences Complications and side effects Excipients Food coloring agents Food colorings Food colouring agents General pharmacology Labeling Medical sciences Miscellaneous Nonprescription drugs Pediatrics Pharmacology. Drug treatments Prescription drugs Side effects |
| title | "Inactive" Ingredients in Pharmaceutical Products: Update (Subject Review) |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-07T11%3A05%3A32IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-gale_proqu&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=%22Inactive%22%20Ingredients%20in%20Pharmaceutical%20Products:%20Update%20(Subject%20Review)&rft.jtitle=Pediatrics%20(Evanston)&rft.au=Committee%20on%20Drugs&rft.aucorp=Committee%20on%20Drugs&rft.date=1997-02-01&rft.volume=99&rft.issue=2&rft.spage=268&rft.epage=278&rft.pages=268-278&rft.issn=0031-4005&rft.eissn=1098-4275&rft.coden=PEDIAU&rft_id=info:doi/10.1542/peds.99.2.268&rft_dat=%3Cgale_proqu%3EA19119512%3C/gale_proqu%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=228356349&rft_id=info:pmid/9024461&rft_galeid=A19119512&rfr_iscdi=true |